Select a Region North America

EVERSANA Named AI Excellence Award Winner for Third Consecutive Year, Recognized in Company Category for 2024

CHICAGO – March 21, 2024 – EVERSANA®, a leading provider of commercialization services to the global life sciences industry, has been awarded an AI Excellence Award from The Business Intelligence Group for the third consecutive year, building on the company’s reputation as a leader in commercial innovation. 

EVERSANA is one of only 35 companies across the globe to be recognized in 2024 for a commitment to innovative, artificial intelligence-driven solutions. The annual awards program recognizes organizations, products and people who bring AI to life and apply it to solve real problems. 

“Innovation is a core value and part of everything we do at EVERSANA. We’ve committed our time and talent to ‘Pharmatize AI’ as we reinvent the way products get to market and how patients get the care they deserve,” said Jim Lang, CEO at EVERSANA. “To again be recognized as a leader in AI excellence is a testament to our organization’s unwavering focus on transformation.” 

EVERSANA’s focus on innovative solutions transcends the organization, from tools to power better employee learning experiences to offerings to drive better health outcomes. In the past year alone, the company has introduced new AI-based solutions to drive new ways of working across the industry, including bringing a new medical regulatory review process to market with Amazon Web Services. EVERSANA was also recognized in both 2023 and 2022 with AI Intelligence Awards.   

A full list of 2024 Artificial Intelligence Award recipients can be found here 


EVERSANA® is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit or connect through LinkedIn and X. 


Media Contact 

Matt Braun 
[email protected]